Forbes Breaking News
@ForbesBreakingNews·5.5M subscribers·180.5K videos
New FDA Approvals For Breast Cancer Drugs Signal 'Exciting' Oncology Progress: AstraZeneca R&D Chief
Posted
June 3, 2026
Views
1,053
Likes
66
Comments
12
June 3, 2026
1,053
66
12
7.41%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
21:15Now PlayingOver the last several weeks, AstraZeneca has received a series of FDA approvals for drugs treating breast cancer. It marks a potentially new phase in understanding this devastating disease. Susan Galbraith, head of oncology R&D at AstraZeneca, joined Forbes senior editor Maggie McGrath to discuss the treatments that were approved and what they mean for patients with breast cancer. "The opportunity to make transformational change in cancer has never been more possible," Galbraith says.
Stay Connected
Forbes Breaking News on X
Forbes Breaking News on TikTok
More From Forbes
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
